97 related articles for article (PubMed ID: 21402067)
21. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.
Vega JL; Puebla C; Vásquez R; Farías M; Alarcón J; Pastor-Anglada M; Krause B; Casanello P; Sobrevia L
Cardiovasc Res; 2009 Jun; 82(3):458-67. PubMed ID: 19193655
[TBL] [Abstract][Full Text] [Related]
22. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.
Damaraju VL; Elwi AN; Hunter C; Carpenter P; Santos C; Barron GM; Sun X; Baldwin SA; Young JD; Mackey JR; Sawyer MB; Cass CE
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F200-11. PubMed ID: 17409283
[TBL] [Abstract][Full Text] [Related]
23. N-linked glycosylation of N48 is required for equilibrative nucleoside transporter 1 (ENT1) function.
Bicket A; Coe IR
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27480168
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry.
Reyes G; Naydenova Z; Abdulla P; Chalsev M; Villani A; Rose JB; Chaudary N; DeSouza L; Siu KW; Coe IR
Protein Expr Purif; 2010 Sep; 73(1):1-9. PubMed ID: 20399865
[TBL] [Abstract][Full Text] [Related]
25. The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters.
Aseervatham J; Tran L; Machaca K; Boudker O
PLoS One; 2015; 10(9):e0136779. PubMed ID: 26406980
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of human equilibrative nucleoside transporter 1 by RNAi enhances 5-fluorouracil response in pancreatic cancer.
Hu X; Chen W; Xu J
Hepatogastroenterology; 2010; 57(104):1567-72. PubMed ID: 21443122
[TBL] [Abstract][Full Text] [Related]
27. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
[TBL] [Abstract][Full Text] [Related]
28. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium.
Casanello P; Torres A; Sanhueza F; González M; Farías M; Gallardo V; Pastor-Anglada M; San Martín R; Sobrevia L
Circ Res; 2005 Jul; 97(1):16-24. PubMed ID: 15933265
[TBL] [Abstract][Full Text] [Related]
29. Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells.
Rehan S; Jaakola VP
Protein Expr Purif; 2015 Oct; 114():99-107. PubMed ID: 26162242
[TBL] [Abstract][Full Text] [Related]
30. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes.
Farías M; San Martín R; Puebla C; Pearson JD; Casado JF; Pastor-Anglada M; Casanello P; Sobrevia L
J Cell Physiol; 2006 Aug; 208(2):451-60. PubMed ID: 16688763
[TBL] [Abstract][Full Text] [Related]
32. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.
Jennings LL; Hao C; Cabrita MA; Vickers MF; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 2001 Apr; 40(5):722-31. PubMed ID: 11311901
[TBL] [Abstract][Full Text] [Related]
33. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium.
Puebla C; Farías M; González M; Vecchiola A; Aguayo C; Krause B; Pastor-Anglada M; Casanello P; Sobrevia L
J Cell Physiol; 2008 Jun; 215(3):645-56. PubMed ID: 18064606
[TBL] [Abstract][Full Text] [Related]
34. Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
Damaraju VL; Visser F; Zhang J; Mowles D; Ng AM; Young JD; Jayaram HN; Cass CE
Mol Pharmacol; 2005 Jan; 67(1):273-9. PubMed ID: 15486050
[TBL] [Abstract][Full Text] [Related]
35. Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin.
Shepshelovich J; Goldstein-Magal L; Globerson A; Yen PM; Rotman-Pikielny P; Hirschberg K
J Cell Sci; 2005 Apr; 118(Pt 8):1577-86. PubMed ID: 15784681
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of human nucleoside transporters in normal and tumor tissue.
Pennycooke M; Chaudary N; Shuralyova I; Zhang Y; Coe IR
Biochem Biophys Res Commun; 2001 Jan; 280(3):951-9. PubMed ID: 11162617
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.
Lai Y; Tse CM; Unadkat JD
J Biol Chem; 2004 Feb; 279(6):4490-7. PubMed ID: 14607828
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of human equilibrative nucleoside transporter 1.
Huang W; Zeng X; Shi Y; Liu M
Protein Cell; 2017 Apr; 8(4):284-295. PubMed ID: 27995448
[TBL] [Abstract][Full Text] [Related]
39. Equilibrative nucleoside transporters-A review.
Boswell-Casteel RC; Hays FA
Nucleosides Nucleotides Nucleic Acids; 2017 Jan; 36(1):7-30. PubMed ID: 27759477
[TBL] [Abstract][Full Text] [Related]
40. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
